Berendsen HH - Search Results

1

Characterization of three small cell lung cancer cell lines established from one patient during longitudinal follow-up.

Berendsen HH, de Leij L, de Vries EG, Mesander G, Mulder NH, de Jong B, Buys CH, Postmus PE, Poppema S, Sluiter HJ, et al. Berendsen HH, et al. Cancer Res. 1988 Dec 1;48(23):6891-9. Cancer Res. 1988. PMID: 2846164

2

A phase II study of high dose epirubicin in unresectable non small cell lung cancer.

Smit EF, Berendsen HH, Piers DA, Smeets J, Riva A, Postmus PE. Smit EF, et al. Among authors: berendsen hh. Br J Cancer. 1992 Mar;65(3):405-8. doi: 10.1038/bjc.1992.82. Br J Cancer. 1992. PMID: 1313691 Free PMC article. Clinical Trial.

3

A feasibility study of testing new drugs for small-cell lung cancer in patients with a poor performance status.

Postmus PE, Smit EF, Berendsen HH, Sleyfer DT. Postmus PE, et al. Among authors: berendsen hh. Cancer Chemother Pharmacol. 1991;27(6):490-1. doi: 10.1007/BF00685167. Cancer Chemother Pharmacol. 1991. PMID: 1849466

4

High-dose etoposide for meningeal carcinomatosis in patients with small cell lung cancer.

Postmus PE, Haaxma-Reiche H, Berendsen HH, Sleijfer DT. Postmus PE, et al. Among authors: berendsen hh. Eur J Cancer Clin Oncol. 1989 Feb;25(2):377-8. doi: 10.1016/0277-5379(89)90033-3. Eur J Cancer Clin Oncol. 1989. PMID: 2539295 No abstract available.

5

Resistance mechanisms in three human small cell lung cancer cell lines established from one patient during clinical follow-up.

de Vries EG, Meijer C, Timmer-Bosscha H, Berendsen HH, de Leij L, Scheper RJ, Mulder NH. de Vries EG, et al. Among authors: berendsen hh. Cancer Res. 1989 Aug 1;49(15):4175-8. Cancer Res. 1989. PMID: 2545337

6

Amplification and expression of different myc-family genes in a tumor specimen and 3 cell lines derived from one small-cell lung cancer patient during longitudinal follow-up.

Kok K, Osinga J, Schotanus DC, Berendsen HH, de Leij LF, Buys CH. Kok K, et al. Among authors: berendsen hh. Int J Cancer. 1989 Jul 15;44(1):75-8. doi: 10.1002/ijc.2910440114. Int J Cancer. 1989. PMID: 2545636

7

Clinical characterization of non-small-cell lung cancer tumors showing neuroendocrine differentiation features.

Berendsen HH, de Leij L, Poppema S, Postmus PE, Boes A, Sluiter HJ, The H. Berendsen HH, et al. J Clin Oncol. 1989 Nov;7(11):1614-20. doi: 10.1200/JCO.1989.7.11.1614. J Clin Oncol. 1989. PMID: 2553880

8

A phase II study of carboplatin and vincristine in previously treated patients with small-cell lung cancer.

Smit EF, Berendsen HH, de Vries EG, Mulder NH, Postmus PE. Smit EF, et al. Among authors: berendsen hh. Cancer Chemother Pharmacol. 1989;25(3):202-4. doi: 10.1007/BF00689583. Cancer Chemother Pharmacol. 1989. PMID: 2557171

9

Phase II evaluation of trans-N3P3Az2(NHMe)4 (AZP) in non-small cell lung cancer.

Postmus PE, Mulder NH, Grampel JC, Meyers WH, Berendsen HH. Postmus PE, et al. Among authors: berendsen hh. Eur J Cancer Clin Oncol. 1987 Aug;23(8):1207-8. doi: 10.1016/0277-5379(87)90156-8. Eur J Cancer Clin Oncol. 1987. PMID: 2820748

10

Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy.

Postmus PE, Berendsen HH, van Zandwijk N, Splinter TA, Burghouts JT, Bakker W. Postmus PE, et al. Among authors: berendsen hh. Eur J Cancer Clin Oncol. 1987 Sep;23(9):1409-11. doi: 10.1016/0277-5379(87)90128-3. Eur J Cancer Clin Oncol. 1987. PMID: 2824211

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters